Rosenblatt started his academic career at UC Davis in 2005 as an assistant professor of ophthalmology and vision science, where he split his time between research in Davis and clinical care in Sacramento.
Rosenblatt said his return to UC Davis Health fills him with a sense of rooted purpose. “I’m so pleased to be back at UC Davis,” he said. “It feels like coming home.”
Before rejoining UC Davis, Rosenblatt served as the G. Stephen Irwin executive dean at the University of Illinois College of Medicine, the chief executive officer of the University of Illinois Hospital and Clinics, and a distinguished professor of ophthalmology and visual sciences at the University of Illinois Chicago.
“UC Davis Health truly stands apart because of the UC Davis Comprehensive Cancer Center,” Rosenblatt said. “A cancer diagnosis is frightening, but it brings tremendous comfort to our community to know there is a cancer center here at home that has the stamp of approval from the National Cancer Institute. We are committed to growing our impact as a place where patients find both world-class care and advanced biomedical science.”
Rosenblatt is an internationally recognized clinician-scientist. He still leads groups of scientists investigating the mechanism of corneal peripheral nerve regeneration following injury, and the use of nanoengineered biomaterials in stem cell delivery to the ocular surface. His research is widely published, including more than 225 original manuscripts, review articles, book chapters and abstracts. He is continuing his research at UC Davis after moving his lab here from Chicago.
Rosenblatt is a graduate of the University of Miami Miller School of Medicine’s Honors Program in Medical Education and the combined M.D./Ph.D. program, receiving his Ph.D. in biochemistry, cell and molecular biology.
